{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:59:11Z","timestamp":1768010351893,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T00:00:00Z","timestamp":1477353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2013R1A1A2009185"],"award-info":[{"award-number":["2013R1A1A2009185"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Samsung Biomedical Research Institute","award":["SMX1161481"],"award-info":[{"award-number":["SMX1161481"]}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI13C2096"],"award-info":[{"award-number":["HI13C2096"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s10549-016-4034-2","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T08:55:19Z","timestamp":1477385719000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer"],"prefix":"10.1007","volume":"161","author":[{"given":"Haeyoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Yeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doo Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mijin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inkyung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Jae","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Jin","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Eon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,25]]},"reference":[{"key":"4034_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas N","year":"2012","unstructured":"Cancer Genome Atlas N (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61\u201370","journal-title":"Nature"},{"key":"4034_CR2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/annonc\/mdv022","volume":"26","author":"S Shiovitz","year":"2015","unstructured":"Shiovitz S, Korde LA (2015) Genetics of breast cancer: a topic in evolution. Ann Oncol 26:1291\u20131299","journal-title":"Ann Oncol"},{"key":"4034_CR3","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372:2243\u20132257","journal-title":"N Engl J Med"},{"key":"4034_CR4","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","volume":"250","author":"JM Hall","year":"1990","unstructured":"Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684\u20131689","journal-title":"Science"},{"key":"4034_CR5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB, New York Breast Cancer Study G (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643\u2013646","journal-title":"Science"},{"key":"4034_CR6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.14694\/EDBK_158817","volume":"35","author":"AW Kurian","year":"2016","unstructured":"Kurian AW, Antoniou AC, Domchek SM (2016) Refining breast cancer risk stratification: additional genes, additional information. Am Soc Clin Oncol Educ book 35:44\u201356","journal-title":"Am Soc Clin Oncol Educ book"},{"key":"4034_CR7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"H Meijers-Heijboer","year":"2002","unstructured":"Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N, Stratton, Consortium CH-BC (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55\u201359","journal-title":"Nat Genet"},{"key":"4034_CR8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2007","unstructured":"Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D, Breast Cancer Susceptibility C, Easton DF, Stratton MR (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39:165\u2013167","journal-title":"Nat Genet"},{"key":"4034_CR9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molonc.2008.09.007","volume":"2","author":"J Bartkova","year":"2008","unstructured":"Bartkova J, Tommiska J, Oplustilova L, Aaltonen K, Tamminen A, Heikkinen T, Mistrik M, Aittomaki K, Blomqvist C, Heikkila P, Lukas J, Nevanlinna H, Bartek J (2008) Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene. Mol Oncol 2:296\u2013316","journal-title":"Mol Oncol"},{"key":"4034_CR10","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1158\/1055-9965.EPI-07-0116","volume":"16","author":"HM Hsu","year":"2007","unstructured":"Hsu HM, Wang HC, Chen ST, Hsu GC, Shen CY, Yu JC (2007) Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11\/Rad50\/Nbs1 complex. Cancer Epidemiol Biomark Prev 16:2024\u20132032","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4034_CR11","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1007\/s13277-013-0830-z","volume":"34","author":"G Zhang","year":"2013","unstructured":"Zhang G, Zeng Y, Liu Z, Wei W (2013) Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk. Tumour Biol 34:2753\u20132757","journal-title":"Tumour Biol"},{"key":"4034_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4048\/jbc.2016.19.1.1","volume":"19","author":"SY Min","year":"2016","unstructured":"Min SY, Kim Z, Hur MH, Yoon CS, Park EH, Jung KW, Korean Breast Cancer Society C (2016) The basic facts of Korean breast cancer in 2013: results of a Nationwide Survey and Breast Cancer Registry Database. J Breast Cancer 19:1\u20137","journal-title":"J Breast Cancer"},{"key":"4034_CR13","volume-title":"SEER Cancer Statistics Review, 1975\u20132012","author":"NNA Howlader","year":"2015","unstructured":"Howlader NNA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2015) SEER Cancer Statistics Review, 1975\u20132012. National Cancer Institute, Bethesda"},{"key":"4034_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-015-3377-4","volume":"151","author":"E Kang","year":"2015","unstructured":"Kang E, Seong MW, Park SK, Lee JW, Lee J, Kim LS, Lee JE, Kim SY, Jeong J, Han SA, Kim SW, Korean Hereditary Breast Cancer Study G (2015) The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Breast Cancer Res Treat 151:157\u2013168","journal-title":"Breast Cancer Res Treat"},{"key":"4034_CR15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.clon.2010.11.007","volume":"23","author":"SA Han","year":"2011","unstructured":"Han SA, Park SK, Ahn SH, Lee MH, Noh DY, Kim LS, Noh WC, Jung Y, Kim KS, Kim SW, Korean Breast Cancer Study G (2011) The Korean Hereditary Breast Cancer (KOHBRA) study: protocols and interim report. Clin Oncol (R Coll Radiol) 23:434\u2013441","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"4034_CR16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248\u2013249","journal-title":"Nat Methods"},{"key":"4034_CR17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073\u20131081","journal-title":"Nat Protoc"},{"key":"4034_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K, Timms K, Garber JE, Herold C, Ellisen L, Krejdovsky J, DeLeonardis K, Sedgwick K, Soltis K, Roa B, Wenstrup RJ, Hartman AR (2015) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121:25\u201333","journal-title":"Cancer"},{"issue":"1","key":"4034_CR19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jmedgenet-2015-103452","volume":"53","author":"J Li","year":"2016","unstructured":"Li J, Meeks H, Feng BJ, Healey S, Thorne H, Makunin I, Ellis J, kConFab I, Campbell I, Southey M, Mitchell G, Clouston D, Kirk J, Goldgar D, Chenevix-Trench G (2016) Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families. J Med Genet 53(1):34\u201342","journal-title":"J Med Genet"},{"key":"4034_CR20","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1245\/s10434-015-4754-2","volume":"22","author":"NS Kapoor","year":"2015","unstructured":"Kapoor NS, Curcio LD, Blakemore CA, Bremner AK, McFarland RE, West JG, Banks KC (2015) Multigene panel testing detects equal rates of pathogenic BRCA1\/2 mutations and has a higher diagnostic yield compared to limited BRCA1\/2 analysis alone in patients at risk for hereditary breast cancer. Ann Surg Oncol 22:3282\u20133288","journal-title":"Ann Surg Oncol"},{"key":"4034_CR21","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.2015.63.7454","volume":"34","author":"ER Thompson","year":"2016","unstructured":"Thompson ER, Rowley SM, Li N, McInerny S, Devereux L, Wong-Brown MW, Trainer AH, Mitchell G, Scott RJ, James PA, Campbell IG (2016) Panel testing for Familial breast cancer: calibrating the tension between research and clinical care. J Clin Oncol 34:1455\u20131459","journal-title":"J Clin Oncol"},{"issue":"4","key":"4034_CR22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/cge.12735","volume":"90","author":"PS Ng","year":"2016","unstructured":"Ng PS, Wen WX, Fadlullah MZ, Yoon SY, Lee SY, Thong MK, Yip CH, Mohd Taib NA, Teo SH (2016) Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing. Clin Genet 90(4):315\u2013323","journal-title":"Clin Genet"},{"key":"4034_CR23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.molcel.2009.09.007","volume":"35","author":"Z Cai","year":"2009","unstructured":"Cai Z, Chehab NH, Pavletich NP (2009) Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase. Mol Cell 35:818\u2013829","journal-title":"Mol Cell"},{"key":"4034_CR24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","volume":"26","author":"M Weischer","year":"2008","unstructured":"Weischer M, Bojesen SE, Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG (2008) CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J Clin Oncol 26:542\u2013548","journal-title":"J Clin Oncol"},{"key":"4034_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cancergen.2015.06.001","volume":"208","author":"F Aloraifi","year":"2015","unstructured":"Aloraifi F, McCartan D, McDevitt T, Green AJ, Bracken A, Geraghty J (2015) Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies. Cancer Genet 208:455\u2013463","journal-title":"Cancer Genet"},{"key":"4034_CR26","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1200\/JCO.2010.34.0778","volume":"29","author":"C Cybulski","year":"2011","unstructured":"Cybulski C, Wokolorczyk D, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Masojc B, Deebniak T, Gorski B, Blecharz P, Narod SA, Lubinski J (2011) Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol 29:3747\u20133752","journal-title":"J Clin Oncol"},{"key":"4034_CR27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10549-007-9878-z","volume":"112","author":"DH Choi","year":"2008","unstructured":"Choi DH, Cho DY, Lee MH, Park HS, Ahn SH, Son BH, Haffty BG (2008) The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation. Breast Cancer Res Treat 112:569\u2013573","journal-title":"Breast Cancer Res Treat"},{"key":"4034_CR28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s12325-008-0057-3","volume":"25","author":"W Chen","year":"2008","unstructured":"Chen W, Yurong S, Liansheng N (2008) Breast cancer low-penetrance allele 1100delC in the CHEK2 gene: not present in the Chinese familial breast cancer population. Adv Ther 25:496\u2013501","journal-title":"Adv Ther"},{"key":"4034_CR29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","volume":"22","author":"B Xia","year":"2006","unstructured":"Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, Liu X, Jasin M, Couch FJ, Livingston DM (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22:719\u2013729","journal-title":"Mol Cell"},{"key":"4034_CR30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejso.2015.01.021","volume":"41","author":"F Aloraifi","year":"2015","unstructured":"Aloraifi F, Alshehhi M, McDevitt T, Cody N, Meany M, O\u2019Doherty A, Quinn CM, Green AJ, Bracken A, Geraghty JG (2015) Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer. Eur J Surg Oncol 41:641\u2013646","journal-title":"Eur J Surg Oncol"},{"key":"4034_CR31","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/humu.22022","volume":"33","author":"M Tischkowitz","year":"2012","unstructured":"Tischkowitz M, Capanu M, Sabbaghian N, Li L, Liang X, Vallee MP, Tavtigian SV, Concannon P, Foulkes WD, Bernstein L, Group WSC, Bernstein JL, Begg CB (2012) Rare germline mutations in PALB2 and breast cancer risk: a population-based study. Hum Mutat 33:674\u2013680","journal-title":"Hum Mutat"},{"key":"4034_CR32","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJMc1410673","volume":"371","author":"AS Lee","year":"2014","unstructured":"Lee AS, Ang P (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:1650\u20131651","journal-title":"N Engl J Med"},{"key":"4034_CR33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13053-016-0049-2","volume":"14","author":"MC Southey","year":"2016","unstructured":"Southey MC, Winship I, Nguyen-Dumont T (2016) PALB2: research reaching to clinical outcomes for women with breast cancer. Hered Cancer Clin Pract 14:9","journal-title":"Hered Cancer Clin Pract"},{"key":"4034_CR34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F, Tomiak E, Neuhausen SL, Teo ZL, Khan S, Aittomaki K, Moilanen JS, Turnbull C, Seal S, Mannermaa A, Kallioniemi A, Lindeman GJ, Buys SS, Andrulis IL, Radice P, Tondini C, Manoukian S, Toland AE, Miron P, Weitzel JN, Domchek SM, Poppe B, Claes KB, Yannoukakos D, Concannon P, Bernstein JL, James PA, Easton DF, Goldgar DE, Hopper JL, Rahman N, Peterlongo P, Nevanlinna H, King MC, Couch FJ, Southey MC, Winqvist R, Foulkes WD, Tischkowitz M (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:497\u2013506","journal-title":"N Engl J Med"},{"key":"4034_CR35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10689-009-9295-z","volume":"9","author":"L Papi","year":"2010","unstructured":"Papi L, Putignano AL, Congregati C, Piaceri I, Zanna I, Sera F, Morrone D, Genuardi M, Palli D (2010) A PALB2 germline mutation associated with hereditary breast cancer in Italy. Fam Cancer 9:181\u2013185","journal-title":"Fam Cancer"},{"key":"4034_CR36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10549-010-0806-2","volume":"122","author":"JH Kim","year":"2010","unstructured":"Kim JH, Choi DH, Cho DY, Ahn SH, Son BH, Haffty BG (2010) PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations. Breast Cancer Res Treat 122:303\u2013306","journal-title":"Breast Cancer Res Treat"},{"key":"4034_CR37","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/carcin\/bgi360","volume":"27","author":"K Heikkinen","year":"2006","unstructured":"Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Knuutila S, Lundan T, Mannermaa A, Borresen-Dale AL, Borg A, Barkardottir RB, Petrini J, Winqvist R (2006) RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 27:1593\u20131599","journal-title":"Carcinogenesis"},{"key":"4034_CR38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-011-1700-2","volume":"133","author":"M He","year":"2012","unstructured":"He M, Di GH, Cao AY, Hu Z, Jin W, Shen ZZ, Shao ZM (2012) RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1\/2 hereditary breast cancer. Breast Cancer Res Treat 133:111\u2013116","journal-title":"Breast Cancer Res Treat"},{"key":"4034_CR39","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1158\/1055-9965.EPI-08-0971","volume":"18","author":"N Uhrhammer","year":"2009","unstructured":"Uhrhammer N, Delort L, Bignon YJ (2009) Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population. Cancer Epidemiol Biomark Prev 18:684\u2013685","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"4034_CR40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, Olson JE, Godwin AK, Pankratz VS, Olswold C, Slettedahl S, Hallberg E, Guidugli L, Davila JI, Beckmann MW, Janni W, Rack B, Ekici AB, Slamon DJ, Konstantopoulou I, Fostira F, Vratimos A, Fountzilas G, Pelttari LM, Tapper WJ, Durcan L, Cross SS, Pilarski R, Shapiro CL, Klemp J, Yao S, Garber J, Cox A, Brauch H, Ambrosone C, Nevanlinna H, Yannoukakos D, Slager SL, Vachon CM, Eccles DM, Fasching PA (2015) Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J Clin Oncol 33:304\u2013311","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4034-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-4034-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-4034-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T22:31:58Z","timestamp":1601159518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-4034-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,25]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["4034"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-4034-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,25]]}}}